Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice

Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF cri...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Cleland, Derrick [verfasserIn] Sathananthan, Matheni Jeganathan, Niranjan

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2022

Schlagwörter:	Interstitial pneumonia with autoimmune features Interstitial lung disease Connective tissue disease Idiopathic pulmonary fibrosis

Anmerkung:	© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Übergeordnetes Werk:	Enthalten in: Current respiratory care reports - New York, NY : Springer, 2012, 11(2022), 4 vom: 22. Okt., Seite 132-150
Übergeordnetes Werk:	volume:11 ; year:2022 ; number:4 ; day:22 ; month:10 ; pages:132-150

Links:	Volltext

DOI / URN:	10.1007/s13665-022-00296-4

Katalog-ID:	SPR048812773

Internformat


LEADER	01000caa a22002652 4500
001	SPR048812773
003	DE-627
005	20230519110850.0
007	cr uuu---uuuuu
008	221206s2022 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s13665-022-00296-4 \|2 doi
035			\|a (DE-627)SPR048812773
035			\|a (SPR)s13665-022-00296-4-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
100	1		\|a Cleland, Derrick \|e verfasserin \|4 aut
245	1	0	\|a Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
520			\|a Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice.
650		4	\|a Interstitial pneumonia with autoimmune features \|7 (dpeaa)DE-He213
650		4	\|a Interstitial lung disease \|7 (dpeaa)DE-He213
650		4	\|a Connective tissue disease \|7 (dpeaa)DE-He213
650		4	\|a Idiopathic pulmonary fibrosis \|7 (dpeaa)DE-He213
700	1		\|a Sathananthan, Matheni \|4 aut
700	1		\|a Jeganathan, Niranjan \|0 (orcid)0000-0001-5533-5105 \|4 aut
773	0	8	\|i Enthalten in \|t Current respiratory care reports \|d New York, NY : Springer, 2012 \|g 11(2022), 4 vom: 22. Okt., Seite 132-150 \|w (DE-627)718610954 \|w (DE-600)2660484-X \|x 2161-332X \|7 nnns
773	1	8	\|g volume:11 \|g year:2022 \|g number:4 \|g day:22 \|g month:10 \|g pages:132-150
856	4	0	\|u https://dx.doi.org/10.1007/s13665-022-00296-4 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_105
912			\|a GBV_ILN_120
912			\|a GBV_ILN_152
912			\|a GBV_ILN_161
912			\|a GBV_ILN_171
912			\|a GBV_ILN_187
912			\|a GBV_ILN_224
912			\|a GBV_ILN_250
912			\|a GBV_ILN_281
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2116
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2119
912			\|a GBV_ILN_2122
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
951			\|a AR
952			\|d 11 \|j 2022 \|e 4 \|b 22 \|c 10 \|h 132-150

Indexfelder

author_variant	d c dc m s ms n j nj
matchkey_str	article:2161332X:2022----::nesiilnuoiwtatimnfaueipiain
hierarchy_sort_str	2022
publishDate	2022
allfields	10.1007/s13665-022-00296-4 doi (DE-627)SPR048812773 (SPR)s13665-022-00296-4-e DE-627 ger DE-627 rakwb eng Cleland, Derrick verfasserin aut Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice. Interstitial pneumonia with autoimmune features (dpeaa)DE-He213 Interstitial lung disease (dpeaa)DE-He213 Connective tissue disease (dpeaa)DE-He213 Idiopathic pulmonary fibrosis (dpeaa)DE-He213 Sathananthan, Matheni aut Jeganathan, Niranjan (orcid)0000-0001-5533-5105 aut Enthalten in Current respiratory care reports New York, NY : Springer, 2012 11(2022), 4 vom: 22. Okt., Seite 132-150 (DE-627)718610954 (DE-600)2660484-X 2161-332X nnns volume:11 year:2022 number:4 day:22 month:10 pages:132-150 https://dx.doi.org/10.1007/s13665-022-00296-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2059 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2106 GBV_ILN_2108 GBV_ILN_2111 GBV_ILN_2116 GBV_ILN_2118 GBV_ILN_2119 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 AR 11 2022 4 22 10 132-150
spelling	10.1007/s13665-022-00296-4 doi (DE-627)SPR048812773 (SPR)s13665-022-00296-4-e DE-627 ger DE-627 rakwb eng Cleland, Derrick verfasserin aut Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice. Interstitial pneumonia with autoimmune features (dpeaa)DE-He213 Interstitial lung disease (dpeaa)DE-He213 Connective tissue disease (dpeaa)DE-He213 Idiopathic pulmonary fibrosis (dpeaa)DE-He213 Sathananthan, Matheni aut Jeganathan, Niranjan (orcid)0000-0001-5533-5105 aut Enthalten in Current respiratory care reports New York, NY : Springer, 2012 11(2022), 4 vom: 22. Okt., Seite 132-150 (DE-627)718610954 (DE-600)2660484-X 2161-332X nnns volume:11 year:2022 number:4 day:22 month:10 pages:132-150 https://dx.doi.org/10.1007/s13665-022-00296-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2059 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2106 GBV_ILN_2108 GBV_ILN_2111 GBV_ILN_2116 GBV_ILN_2118 GBV_ILN_2119 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 AR 11 2022 4 22 10 132-150
allfields_unstemmed	10.1007/s13665-022-00296-4 doi (DE-627)SPR048812773 (SPR)s13665-022-00296-4-e DE-627 ger DE-627 rakwb eng Cleland, Derrick verfasserin aut Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice. Interstitial pneumonia with autoimmune features (dpeaa)DE-He213 Interstitial lung disease (dpeaa)DE-He213 Connective tissue disease (dpeaa)DE-He213 Idiopathic pulmonary fibrosis (dpeaa)DE-He213 Sathananthan, Matheni aut Jeganathan, Niranjan (orcid)0000-0001-5533-5105 aut Enthalten in Current respiratory care reports New York, NY : Springer, 2012 11(2022), 4 vom: 22. Okt., Seite 132-150 (DE-627)718610954 (DE-600)2660484-X 2161-332X nnns volume:11 year:2022 number:4 day:22 month:10 pages:132-150 https://dx.doi.org/10.1007/s13665-022-00296-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2059 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2106 GBV_ILN_2108 GBV_ILN_2111 GBV_ILN_2116 GBV_ILN_2118 GBV_ILN_2119 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 AR 11 2022 4 22 10 132-150
allfieldsGer	10.1007/s13665-022-00296-4 doi (DE-627)SPR048812773 (SPR)s13665-022-00296-4-e DE-627 ger DE-627 rakwb eng Cleland, Derrick verfasserin aut Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice. Interstitial pneumonia with autoimmune features (dpeaa)DE-He213 Interstitial lung disease (dpeaa)DE-He213 Connective tissue disease (dpeaa)DE-He213 Idiopathic pulmonary fibrosis (dpeaa)DE-He213 Sathananthan, Matheni aut Jeganathan, Niranjan (orcid)0000-0001-5533-5105 aut Enthalten in Current respiratory care reports New York, NY : Springer, 2012 11(2022), 4 vom: 22. Okt., Seite 132-150 (DE-627)718610954 (DE-600)2660484-X 2161-332X nnns volume:11 year:2022 number:4 day:22 month:10 pages:132-150 https://dx.doi.org/10.1007/s13665-022-00296-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2059 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2106 GBV_ILN_2108 GBV_ILN_2111 GBV_ILN_2116 GBV_ILN_2118 GBV_ILN_2119 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 AR 11 2022 4 22 10 132-150
allfieldsSound	10.1007/s13665-022-00296-4 doi (DE-627)SPR048812773 (SPR)s13665-022-00296-4-e DE-627 ger DE-627 rakwb eng Cleland, Derrick verfasserin aut Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice. Interstitial pneumonia with autoimmune features (dpeaa)DE-He213 Interstitial lung disease (dpeaa)DE-He213 Connective tissue disease (dpeaa)DE-He213 Idiopathic pulmonary fibrosis (dpeaa)DE-He213 Sathananthan, Matheni aut Jeganathan, Niranjan (orcid)0000-0001-5533-5105 aut Enthalten in Current respiratory care reports New York, NY : Springer, 2012 11(2022), 4 vom: 22. Okt., Seite 132-150 (DE-627)718610954 (DE-600)2660484-X 2161-332X nnns volume:11 year:2022 number:4 day:22 month:10 pages:132-150 https://dx.doi.org/10.1007/s13665-022-00296-4 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2059 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2106 GBV_ILN_2108 GBV_ILN_2111 GBV_ILN_2116 GBV_ILN_2118 GBV_ILN_2119 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 AR 11 2022 4 22 10 132-150
language	English
source	Enthalten in Current respiratory care reports 11(2022), 4 vom: 22. Okt., Seite 132-150 volume:11 year:2022 number:4 day:22 month:10 pages:132-150
sourceStr	Enthalten in Current respiratory care reports 11(2022), 4 vom: 22. Okt., Seite 132-150 volume:11 year:2022 number:4 day:22 month:10 pages:132-150
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Interstitial pneumonia with autoimmune features Interstitial lung disease Connective tissue disease Idiopathic pulmonary fibrosis
isfreeaccess_bool	false
container_title	Current respiratory care reports
authorswithroles_txt_mv	Cleland, Derrick @@aut@@ Sathananthan, Matheni @@aut@@ Jeganathan, Niranjan @@aut@@
publishDateDaySort_date	2022-10-22T00:00:00Z
hierarchy_top_id	718610954
id	SPR048812773
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR048812773</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519110850.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221206s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s13665-022-00296-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR048812773</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13665-022-00296-4-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cleland, Derrick</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interstitial pneumonia with autoimmune features</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interstitial lung disease</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Connective tissue disease</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Idiopathic pulmonary fibrosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sathananthan, Matheni</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jeganathan, Niranjan</subfield><subfield code="0">(orcid)0000-0001-5533-5105</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current respiratory care reports</subfield><subfield code="d">New York, NY : Springer, 2012</subfield><subfield code="g">11(2022), 4 vom: 22. Okt., Seite 132-150</subfield><subfield code="w">(DE-627)718610954</subfield><subfield code="w">(DE-600)2660484-X</subfield><subfield code="x">2161-332X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:4</subfield><subfield code="g">day:22</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:132-150</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s13665-022-00296-4</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_250</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_281</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2031</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2039</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2106</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2108</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2116</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2119</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2144</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2022</subfield><subfield code="e">4</subfield><subfield code="b">22</subfield><subfield code="c">10</subfield><subfield code="h">132-150</subfield></datafield></record></collection>
author	Cleland, Derrick
spellingShingle	Cleland, Derrick misc Interstitial pneumonia with autoimmune features misc Interstitial lung disease misc Connective tissue disease misc Idiopathic pulmonary fibrosis Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice
authorStr	Cleland, Derrick
ppnlink_with_tag_str_mv	@@773@@(DE-627)718610954
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2161-332X
topic_title	Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice Interstitial pneumonia with autoimmune features (dpeaa)DE-He213 Interstitial lung disease (dpeaa)DE-He213 Connective tissue disease (dpeaa)DE-He213 Idiopathic pulmonary fibrosis (dpeaa)DE-He213
topic	misc Interstitial pneumonia with autoimmune features misc Interstitial lung disease misc Connective tissue disease misc Idiopathic pulmonary fibrosis
topic_unstemmed	misc Interstitial pneumonia with autoimmune features misc Interstitial lung disease misc Connective tissue disease misc Idiopathic pulmonary fibrosis
topic_browse	misc Interstitial pneumonia with autoimmune features misc Interstitial lung disease misc Connective tissue disease misc Idiopathic pulmonary fibrosis
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Current respiratory care reports
hierarchy_parent_id	718610954
hierarchy_top_title	Current respiratory care reports
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)718610954 (DE-600)2660484-X
title	Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice
ctrlnum	(DE-627)SPR048812773 (SPR)s13665-022-00296-4-e
title_full	Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice
author_sort	Cleland, Derrick
journal	Current respiratory care reports
journalStr	Current respiratory care reports
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2022
contenttype_str_mv	txt
container_start_page	132
author_browse	Cleland, Derrick Sathananthan, Matheni Jeganathan, Niranjan
container_volume	11
format_se	Elektronische Aufsätze
author-letter	Cleland, Derrick
doi_str_mv	10.1007/s13665-022-00296-4
normlink	(ORCID)0000-0001-5533-5105
normlink_prefix_str_mv	(orcid)0000-0001-5533-5105
title_sort	interstitial pneumonia with autoimmune features: implications for clinical practice
title_auth	Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice
abstract	Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
abstractGer	Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
abstract_unstemmed	Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2031 GBV_ILN_2034 GBV_ILN_2037 GBV_ILN_2039 GBV_ILN_2044 GBV_ILN_2059 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2106 GBV_ILN_2108 GBV_ILN_2111 GBV_ILN_2116 GBV_ILN_2118 GBV_ILN_2119 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2144 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153
container_issue	4
title_short	Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice
url	https://dx.doi.org/10.1007/s13665-022-00296-4
remote_bool	true
author2	Sathananthan, Matheni Jeganathan, Niranjan
author2Str	Sathananthan, Matheni Jeganathan, Niranjan
ppnlink	718610954
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1007/s13665-022-00296-4
up_date	2024-07-03T21:37:58.791Z
_version_	1803595471957000192
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR048812773</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519110850.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">221206s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s13665-022-00296-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR048812773</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13665-022-00296-4-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cleland, Derrick</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Purpose of Review Interstitial pneumonia with autoimmune features (IPAF) is a research term that was proposed in 2015 to uniformly define patients with an idiopathic interstitial lung disease with subtle features of underlying autoimmunity. In this article, we reviewed studies that utilized IPAF criteria and examined the implications of this classification in clinical practice. Recent Findings There were significant differences in the clinical characteristics and outcomes of the IPAF cohorts suggesting that the interpretation and application of the IPAF criteria are variable. Despite these differences, numerous studies noted that a substantial number of patients with IPAF developed a definite connective tissue disease, and the survival rate for IPAF is likely in-between that of idiopathic pulmonary fibrosis and connective tissue disease–related interstitial lung diseases. Summary Further refinement of the IPAF criteria and larger prospective studies are needed to better understand the implications of IPAF in clinical practice.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interstitial pneumonia with autoimmune features</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interstitial lung disease</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Connective tissue disease</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Idiopathic pulmonary fibrosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sathananthan, Matheni</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jeganathan, Niranjan</subfield><subfield code="0">(orcid)0000-0001-5533-5105</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current respiratory care reports</subfield><subfield code="d">New York, NY : Springer, 2012</subfield><subfield code="g">11(2022), 4 vom: 22. Okt., Seite 132-150</subfield><subfield code="w">(DE-627)718610954</subfield><subfield code="w">(DE-600)2660484-X</subfield><subfield code="x">2161-332X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:11</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:4</subfield><subfield code="g">day:22</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:132-150</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s13665-022-00296-4</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_250</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_281</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2031</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2039</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2106</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2108</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2116</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2119</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2144</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">11</subfield><subfield code="j">2022</subfield><subfield code="e">4</subfield><subfield code="b">22</subfield><subfield code="c">10</subfield><subfield code="h">132-150</subfield></datafield></record></collection>
score	7.398575

Nicht das Richtige dabei?

Schreiben Sie uns!

Interstitial Pneumonia with Autoimmune Features: Implications for Clinical Practice

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?